Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Type of study
Language
Publication year range
1.
Ann Hepatol ; 3(3): 118-20, 2004.
Article in English | MEDLINE | ID: mdl-15505599

ABSTRACT

We describe the case of a 36-years-old male patient, originating from India, who presented with enlarged cervical lymph nodes and elevated liver chemistry tests. Histologically necrosing granulomas were observed in the lymph nodes, and PCR revealed DNA from mycobacterium tuberculosis. However, in the liver biopsy granulomatous hepatitis without central necrosis was seen. With a positive PCR for mycobacteria from liver tissue and no evidence for other hepatic diseases we started drug treatment with standard quadruple regimen consisting of isoniazid, rifampicin, ethambutol, and pyrazinamide. Five days after onset of therapy, liver chemistry tests rose 10-fold, forcing us to interrupt treatment. Gradual step-wise re-exposition with the same medication after return of liver chemistry tests to baseline was well tolerated without any further side effects. Liver involvement of tuberculosis can have many facets and may be treated by gradual dosing of standard drugs.


Subject(s)
Antitubercular Agents/administration & dosage , Isoniazid/administration & dosage , Liver/drug effects , Tuberculosis, Hepatic/drug therapy , Tuberculosis, Miliary/drug therapy , Adult , Antitubercular Agents/adverse effects , Biopsy , Chemical and Drug Induced Liver Injury/etiology , Drug Therapy, Combination , Ethambutol/administration & dosage , Ethambutol/adverse effects , Humans , Isoniazid/adverse effects , Liver/microbiology , Liver/pathology , Lymph Nodes/pathology , Male , Pyrazinamide/administration & dosage , Pyrazinamide/adverse effects , Rifampin/administration & dosage , Rifampin/adverse effects , Tuberculosis, Hepatic/pathology , Tuberculosis, Miliary/pathology
SELECTION OF CITATIONS
SEARCH DETAIL